A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

Item
http://www.wikidata.org/entity/Q28261215
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis.Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives.Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease.SLC9A9 Co-expression modules in autism-associated brain regions.Personalised medicine for multiple sclerosis care.Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.Genetic Variants and Multiple Sclerosis Risk Gene SLC9A9 Expression in Distinct Human Brain Regions.The era of GWAS is over - No.Genome-wide scan identifies candidate loci related to remifentanil requirements during laparoscopic-assisted colectomy.Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis.
P2860

A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

Item
http://www.wikidata.org/entity/Q28261215
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@ast
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@en
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@nl
type
label
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@ast
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@en
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@nl
prefLabel
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@ast
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@en
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921